The days of rapid growth and high margin levels are no more for the pharmaceutical industry. In order to continue delivering high and attractive profitability ratios, the industry is now faced with the same pressure to achieve excellence in cost optimization facing other industries. Pharmaceutical companies need to gain improved control over their overall cost base and a greater ability to variabilize fixed costs.

Contributors: Oliver Wyman
Categories: Whitepaper
SRC Type: Outsourcing, Procurement Outsourcing / Transformation